172 related articles for article (PubMed ID: 2180591)
21. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Chen YH; Liu RC; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of angina pectoris with perhexiline maleate. Clinical evaluation in controlled double-blind study with placebo and prenylamine].
Dalla Volta S; Episcopo U; Gemelli A; Permutti B
Minerva Cardioangiol; 1976 Feb; 24(2):137-47. PubMed ID: 768808
[No Abstract] [Full Text] [Related]
23. A multicentre trial of perhexiline maleate in the treatment of angina pectoris.
Hitchcock PJ; Rutovitz IJ; Dando RV; Eathorne AJ; Weiss G
Curr Ther Res Clin Exp; 1977 Jan; 21(1):36-42. PubMed ID: 401710
[No Abstract] [Full Text] [Related]
24. [Experimental study on a new antianginal drug: perhexiline maleate].
del Guercio R
Clin Ter; 1975 Apr; 73(1):57-71. PubMed ID: 773594
[No Abstract] [Full Text] [Related]
25. Investigations of long-term treatment with perhexiline maleate using therapeutic monitoring and electromyography.
Pilcher J; Cooper JD; Turnell DC; Matenga J; Paul R; Lockhart JD
Ther Drug Monit; 1985; 7(1):54-60. PubMed ID: 3992623
[TBL] [Abstract][Full Text] [Related]
26. Perhexiline maleate in the treatment of severe angina pectoris.
Horowitz JD; Mashford ML
Med J Aust; 1979 Jun; 1(11):485-8. PubMed ID: 470697
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
28. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
29. The treatment of angina pectoris. A trial of perhexiline maleate in patients with angiographically normal coronary arteries.
Day LJ; Sowton E
Practitioner; 1978 Jun; 220(1320):965-8. PubMed ID: 356021
[No Abstract] [Full Text] [Related]
30. [Clinical trial by perexiline maleate in treatment of angina pectoris (author's transl)].
Corsini G; Correale E; Oriani G; Persico S; Tritto C
G Ital Cardiol; 1975; 5(1):73-86. PubMed ID: 1120556
[TBL] [Abstract][Full Text] [Related]
31. Proceedings: Perhexiline maleate in the treatment of angina pectoris: a double-blind trial.
Gitlin N; Nellen M
Postgrad Med J; 1973 Apr; 49():Suppl 3:100-4. PubMed ID: 4587024
[No Abstract] [Full Text] [Related]
32. [Treatment of angina pectoris with perhexiline maleate. Results and secondary effects].
RodrÃguez Lambert JL; Simarro E; Moris C; Sieres M; Cortina A; MartÃnez C; Rodrigo L; Prado LS
Rev Esp Cardiol; 1984; 37(6):431-3. PubMed ID: 6522775
[No Abstract] [Full Text] [Related]
33. Proceedings: Clinical results with a new antianginal drug (perhexiline maleate).
Hoekenga MT; Bunde CA; Cawein MJ; Kuzma RJ; Griffin CL
Postgrad Med J; 1973 Apr; 49():Suppl 3:95-9. PubMed ID: 4587041
[No Abstract] [Full Text] [Related]
34. A multicentre trial of perhexiline maleate, beta-blocker and placebo in angina pectoris.
Armstrong ML; Brand D; Emmett AJ; Hodge JL; Kellaway GS; Mestitz P; Reefman M; Wallace DC
Med J Aust; 1974 Sep; 2(11):389-93. PubMed ID: 4154390
[No Abstract] [Full Text] [Related]
35. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
Picano E;
Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
[TBL] [Abstract][Full Text] [Related]
36. Perhexiline maleate induced cirrhosis.
Pieterse AS; Rowland R; Dunn D
Pathology; 1983 Apr; 15(2):201-3. PubMed ID: 6888970
[TBL] [Abstract][Full Text] [Related]
37. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
38. Relationship between plasma perhexiline concentration and symptomatic status during short-term perhexiline therapy.
Stewart S; Voss DW; Northey DL; Horowitz JD
Ther Drug Monit; 1996 Dec; 18(6):635-9. PubMed ID: 8946658
[TBL] [Abstract][Full Text] [Related]
39. Report of a multicentre monitored release study of perhexiline maleate in the prevention of angina pectoris.
Lockhart JD; Masheter HC
Br J Clin Pract; 1976 Sep; 30(9):172-7. PubMed ID: 826264
[No Abstract] [Full Text] [Related]
40. Proceedings: Effects of perhexiline maleate in angina pectoris: a double-blind clinical evaluation with ECG-treadmill exercise testing.
Morledge J
Postgrad Med J; 1973 Apr; 49():Suppl 3:64-7. PubMed ID: 4587034
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
